Healthcare Press Releases

Withings announced the launch of Withings BodyFit ($279.95), an at-home body composition scale delivering 6-zone segmental analysis via its retractable handle, giving athletes, fitness-focused individuals, and individuals trying to lose weight the physiological precision previously reserved for clinical settings. For GLP-1 users, Withings BodyFit provides the precise, actionable insights to ensure weight loss targets fat while actively protecting crucial muscle mass.

Waters Corporation announced the launch of the Waters Cyclic IMS P20 Mass Spectrometer, a high-resolution structural and spatial omics platform designed to help scientists see biology more clearly, and act on it faster. Combining multipass Cyclic Ion Mobility Spectrometry with an enhanced suite of fragmentation, probing, and imaging capabilities, this unique and powerful instrument delivers confident insights for the early detection of disease signals, from protein misfolding to post-translational modifications.

Mindray, a global leader in healthcare innovation across perioperative, medical imaging, and critical care, announced the launch of its upgraded Hepatus-Series Ultrasound Systems, a groundbreaking advancement that elevates gastroenterology imaging to new heights.

Waters Corporation announced that the BD BACTEC FXI Culture System has received U.S. Food and Drug Administration (FDA) 510(k) clearance.

Koning Health, manufacturer of the Koning Vera Breast CT, announced the launch of its newly redesigned website, koninghealth.com, as the company continues to build momentum in the advanced breast imaging market. The launch comes alongside Koning's newest installation at Vital View in Seattle, Washington, further reflecting the company's expanding U.S. footprint and continued progress as an advanced imaging modality.

Soterix Medical Inc., the global leader in non-invasive stimulation and integrated brain monitoring technologies, announced clearance from the U.S. Food & Drug Administration (FDA) for the SPRY Transcranial Magnetic Stimulation (TMS) Therapy. SPRY TMS is indicated for the treatment of Major Depressive Disorder in adult patients, who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. 

MGI Tech Co., Ltd. a company dedicated to developing core tools and technologies that drive innovation in the life sciences, announced the acquisition of STOmics and CycloneSEQ. It marks a significant milestone in MGI's "SEQALL+GLI+Omics" strategy, positioning the company as the world's only manufacturer of core life science tools spanning short-read sequencing, long-read nanopore sequencing, generative lab intelligence and spatial omics technologies.

Flosonics Medical announced that its FloPatch wearable Doppler ultrasound device has received an Innovative Technology contract from Vizient®, the nation’s largest provider-driven healthcare performance improvement company. The contract was awarded following review by hospital experts serving on one of Vizient’s client-led councils, who identified FloPatch’s unique potential to improve fluid management decisions and patient outcomes in sepsis care.

Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, announced the newest addition to its CN-Series, the CN-9000 Automated Hemostasis Solution.

Dymicron®, a privately held medical device company pioneering advanced spinal technologies, announced the successful enrollment and treatment of the first patient in its Triadyme®-C Investigational Device Exemption (IDE) clinical trial.